{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:44:57Z","timestamp":1790905497241,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologie Biologie"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.patbio.2006.07.008","type":"journal-article","created":{"date-parts":[[2006,10,6]],"date-time":"2006-10-06T12:59:46Z","timestamp":1160139586000},"page":"541-544","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation by\u00a0Q-RTPCR of\u00a0the\u00a0efficacy of\u00a0ribavirin complexed with beta-cyclodextrin against\u00a0measles virus in\u00a0a\u00a0mouse encephalitis model"],"prefix":"10.1016","volume":"54","author":[{"given":"H.","family":"Jeulin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Grancher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Kedzierewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.E.","family":"Le Faou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Venard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.patbio.2006.07.008_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1128\/AAC.3.2.235","article-title":"In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses","volume":"3","author":"Huffman","year":"1973","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.patbio.2006.07.008_bib2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/clinids\/19.3.454","article-title":"Severe measles pneumonitis in adults: evaluation of clinical characteristics and therapy with intravenous ribavirin","volume":"19","author":"Forni","year":"1994","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.patbio.2006.07.008_bib3","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1128\/AAC.48.12.4631-4635.2004","article-title":"Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis","volume":"48","author":"Hosoya","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.patbio.2006.07.008_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399402004696","article-title":"Measles virus and immunomodulation: molecular bases and perspectives","author":"Schneider-Schaulies","year":"2002","journal-title":"Expert. Rev. Mol. Med."},{"issue":"2","key":"10.1016\/j.patbio.2006.07.008_bib5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/mi.3.2.90","article-title":"Blood-brain barrier drug targeting: the future of brain drug development","volume":"3","author":"Pardridge","year":"2003","journal-title":"Mol. Interv."},{"issue":"1","key":"10.1016\/j.patbio.2006.07.008_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/AAC.32.1.117","article-title":"Pharmacokinetics of ribavirin aerosol in mice","volume":"32","author":"Gilbert","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.patbio.2006.07.008_bib7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1128\/AAC.38.4.653","article-title":"Effect of ribavirin on subacute sclerosing panencephalitis virus infections in hamsters","volume":"38","author":"Honda","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.patbio.2006.07.008_bib8","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1517\/13543776.9.12.1697","article-title":"A review of recent applications of cyclodextrins for drug discovery","volume":"9","author":"Zhang","year":"1999","journal-title":"Expert Opinion on Therapeutic Patents"},{"issue":"2","key":"10.1016\/j.patbio.2006.07.008_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0166-3542(01)00218-2","article-title":"In vitro antiviral efficacy of the ganciclovir complexed with beta-cyclodextrin on human cytomegalovirus clinical strains","volume":"54","author":"Nicolazzi","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.patbio.2006.07.008_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10847-005-0170-8","article-title":"Physicochemical Study of Ribavirin Complexes with alpha-, b\u00eata- and gamma-Cyclodextrins","volume":"51","author":"Grancher","year":"2005","journal-title":"J. Incl. Phenom. Macroc. Chem."},{"issue":"3","key":"10.1016\/j.patbio.2006.07.008_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.antiviral.2004.01.003","article-title":"Improved antiviral activity in vitro of ribavirin against measles virus after complexation with cyclodextrins","volume":"62","author":"Grancher","year":"2004","journal-title":"Antiviral Res."},{"issue":"3","key":"10.1016\/j.patbio.2006.07.008_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ejpb.2004.01.001","article-title":"The influence of absorption enhancers on nasal absorption of acyclovir","volume":"57","author":"Chavanpatil","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.patbio.2006.07.008_bib13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/mp.55.2.84","article-title":"Potential viral pathogenic mechanism for new variant inflammatory bowel disease","volume":"55","author":"Uhlmann","year":"2002","journal-title":"Mol. Pathol."},{"issue":"8","key":"10.1016\/j.patbio.2006.07.008_bib14","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.bmcl.2006.01.049","article-title":"Methylated beta-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood-brain barrier","volume":"16","author":"Tilloy","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.patbio.2006.07.008_bib15","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/IAI.21.3.764-770.1978","article-title":"Susceptibility of mice to acute and persistent measles infection","volume":"21","author":"Neighbour","year":"1978","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.patbio.2006.07.008_bib16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1124\/jpet.104.067512","article-title":"Behavior of alpha-, beta-, and gamma-cyclodextrins and their derivatives on an in vitro model of blood-brain barrier","volume":"310","author":"Monnaert","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.patbio.2006.07.008_bib17","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/JCM.38.3.1113-1120.2000","article-title":"Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5","volume":"38","author":"Elbeik","year":"2000","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"10.1016\/j.patbio.2006.07.008_bib18","first-page":"736","article-title":"Low molecular weight polyethylenimines linked by beta-cyclodextrin for gene transfer into the nervous system","volume":"8","author":"Tang","year":"2006","journal-title":"J. Genet. Med."},{"issue":"1-2","key":"10.1016\/j.patbio.2006.07.008_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2005.11.022","article-title":"Lack of effect of beta-cyclodextrin and its water-soluble derivatives on in vitro drug transport across rat intestinal epithelium","volume":"309","author":"Zheng","year":"2006","journal-title":"Int. J. Pharm."}],"container-title":["Pathologie Biologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811406001398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811406001398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T13:01:50Z","timestamp":1587214910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0369811406001398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0369811406001398"],"URL":"https:\/\/doi.org\/10.1016\/j.patbio.2006.07.008","relation":{},"ISSN":["0369-8114"],"issn-type":[{"value":"0369-8114","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}